Viridian Therapeutics, Inc. · NASDAQ:VRDN

Kynam Capital Management, LP reported a 5.76% stake in Viridian Therapeutics, Inc. (Schedule 13G)

Event Mar 31, 2025 · Filed May 15, 2025

Kynam Capital Management, LP reported a 5.76% stake in Viridian Therapeutics, Inc., 0 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G).

Stake
5.76%
Shares
0
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Kynam Capital Management, LP5.76%0
Kynam Capital Management GP, LLC5.76%0
Yue Tang5.76%0

Source

View original at SEC

Related